Literature DB >> 9161645

Reliability of a modified medication appropriateness index in ambulatory older persons.

L S Fitzgerald1, J T Hanlon, P S Shelton, P B Landsman, K E Schmader, C C Pulliam, M E Williams.   

Abstract

OBJECTIVE: To evaluate the reliability of a medication appropriateness index (MAI) modified for elderly outpatients in a non-Veterans Affairs setting.
DESIGN: Reliability study.
SETTING: General community. PARTICIPANTS: Ten community-dwelling elderly (> 65 y) taking five or more regularly scheduled medications and participating in a university-based health service intervention study. MAIN OUTCOME MEASURES: Interrater reliability of MAI ratings of 65 medications made by two clinical pharmacists for individual items and for an overall summed score was calculated by use of kappa statistics and intraclass correlation coefficient.
RESULTS: The interrater agreement for each of the individual MAI items was high for both appropriate and inappropriate ratings and ranged from 80% to 100% (overall kappa = 0.64). Overall agreement for the summed score was good (intraclass correlation = 0.80).
CONCLUSIONS: The modified MAI is a reliable instrument for evaluation of medication appropriateness in a non-Veterans Affairs, ambulatory, elderly population and may provide pharmacists with a practical and standard method to evaluate patients' drug regimens and identify some potential drug-related problems.

Entities:  

Mesh:

Year:  1997        PMID: 9161645     DOI: 10.1177/106002809703100503

Source DB:  PubMed          Journal:  Ann Pharmacother        ISSN: 1060-0280            Impact factor:   3.154


  31 in total

Review 1.  Assessing medication appropriateness in the elderly: a review of available measures.

Authors:  P S Shelton; M A Fritsch; M A Scott
Journal:  Drugs Aging       Date:  2000-06       Impact factor: 3.923

2.  Development of a quality use of medicines coding system to rate clinical pharmacists' medication review recommendations.

Authors:  Lene Sorensen; Mendel P Grobler; Michael S Roberts
Journal:  Pharm World Sci       Date:  2003-10

Review 3.  Inappropriate prescribing: criteria, detection and prevention.

Authors:  Marie N O'Connor; Paul Gallagher; Denis O'Mahony
Journal:  Drugs Aging       Date:  2012-06-01       Impact factor: 3.923

4.  Development and validation of a new Prescription Quality Index.

Authors:  Norul Badriah Hassan; Hasanah Che Ismail; Lin Naing; Ronán M Conroy; Abdul Rashid Abdul Rahman
Journal:  Br J Clin Pharmacol       Date:  2010-10       Impact factor: 4.335

Review 5.  Polypharmacy in older adults with cancer.

Authors:  Ronald J Maggiore; Cary P Gross; Arti Hurria
Journal:  Oncologist       Date:  2010-04-24

Review 6.  Medication-indication knowledge bases: a systematic review and critical appraisal.

Authors:  Hojjat Salmasian; Tran H Tran; Herbert S Chase; Carol Friedman
Journal:  J Am Med Inform Assoc       Date:  2015-09-02       Impact factor: 4.497

7.  Inter-rater reliability of explicit indicators of prescribing appropriateness.

Authors:  Mary P Tully; Judith A Cantrill
Journal:  Pharm World Sci       Date:  2005-08

8.  Pharmacists' and pharmacy students' ability to identify drug-related problems using TIMER (Tool to Improve Medications in the Elderly via Review).

Authors:  Sarah Snyder Lee; Ann K Schwemm; Jeffrey Reist; Matthew Cantrell; Michael Andreski; William R Doucette; Elizabeth A Chrischilles; Karen B Farris
Journal:  Am J Pharm Educ       Date:  2009-05-27       Impact factor: 2.047

9.  Combined intervention programme reduces inappropriate prescribing in elderly patients exposed to polypharmacy in primary care.

Authors:  L Bregnhøj; S Thirstrup; M B Kristensen; L Bjerrum; J Sonne
Journal:  Eur J Clin Pharmacol       Date:  2008-09-21       Impact factor: 2.953

10.  Impact of Pharmacist-Provided Medication Therapy Management on Healthcare Quality and Utilization in Recently Discharged Elderly Patients.

Authors:  Jordan D Haag; Amanda Z Davis; Robert W Hoel; Jeffrey J Armon; Laura J Odell; Ross A Dierkhising; Paul Y Takahashi
Journal:  Am Health Drug Benefits       Date:  2016-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.